Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum

Starting soon · Not applicable

Conditions studied: Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing

In brief

The purpose of the clinical investigation is to evaluate the safety and performances of the new LINEA cardiac pacing lead, intended for placement at the interventricular septum.

Key facts

Study ID

NCT07342608

Run by

MicroPort CRM

People needed

450

Starts

2026-03-31

Expected to finish

2030-04-30

Last updated by the study team

2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.